These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6504768)

  • 1. On the origin and histological structure of adenocarcinoma of the endocervix in women under 50 years of age.
    Dallenbach-Hellweg G
    Pathol Res Pract; 1984 Sep; 179(1):38-50. PubMed ID: 6504768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Occurrence and histological structure of adenocarcinoma of the endocervix after long-term use of oral contraceptives (author's transl)].
    Dallenbach-Hellweg G
    Geburtshilfe Frauenheilkd; 1982 Apr; 42(4):249-55. PubMed ID: 6920328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemics.
    Netw Res Triangle Park N C; 1985; 6(3):1-3. PubMed ID: 12280131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver function tests in patients on oral progestogens.
    Engineer AD; Gupta V; Tandon P
    J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Morphofunctional features of the cervix uteri in women using hormonal contraception].
    Prilepskaia VN; Kondrikov NI; Nazarova NM
    Akush Ginekol (Mosk); 1991 Dec; (12):6-10. PubMed ID: 1789353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum lipid studies in women using combination type of oral contraceptives.
    Vaidya R; Purandare VN; Nain S; Gupta K; Rajwade N; Sheth UK
    J Obstet Gynaecol India; 1979 Jun; 29(3):644-6. PubMed ID: 12335922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical adenocarcinoma in young women: possible relationship to microglandular hyperplasia and use of oral contraceptives.
    Jones MW; Silverberg SG
    Obstet Gynecol; 1989 Jun; 73(6):984-9. PubMed ID: 2726119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Problems in evaluating chronic toxicity of contraceptive steroids in dogs.
    Weikel JH; Nelson LW
    J Toxicol Environ Health; 1977 Sep; 3(1-2):167-77. PubMed ID: 72828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possible link between long-term oral contraceptive use and cervical cancer].
    Perspect Int Planif Fam; 1987; (Spec No):40-1. PubMed ID: 12269054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some aspects of studies with oral contraceptives in Indian women.
    Shah PN
    J Obstet Gynaecol India; 1966 Aug; 16(4):409-14. PubMed ID: 12262163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipids and blood coagulation studies in women using steroidal hormones for contraception.
    Hashmi JA; Kazi AB; Kazi A; Ali N
    J Pak Med Assoc (1951); 1972 Aug; 22(8):218-25. PubMed ID: 12305803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospitalizations among black women using contraceptives.
    Higgins JE; Wilkens LR; Chi IC; Hatcher RA
    Am J Obstet Gynecol; 1985 Oct; 153(3):280-7. PubMed ID: 2931987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptives.
    Maclennan AH
    Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas.
    Lacey JV; Brinton LA; Abbas FM; Barnes WA; Gravitt PE; Greenberg MD; Greene SM; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Silverberg SG; Hildesheim A
    Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1079-85. PubMed ID: 10613340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraception and the big "C".
    Chandran R
    Malays J Reprod Health; 1992 Jun; 10(1):1-5. PubMed ID: 12345024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cribriform polypoid adenomatous (atypical) hyperplasia of the endocervical glands of the uterus under hormonal contraception.
    Moltz L; Becker K
    Eur J Obstet Gynecol Reprod Biol; 1977; 7(5):331-6. PubMed ID: 264059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormonal contraception--side effects and surgical aspects (author's transl)].
    Göretzlehner G; Carol W; Köhler G
    Zentralbl Chir; 1980; 105(24):1601-16. PubMed ID: 7015744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.